Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025

Clinical trial NCT03907540 · COMPLETED

Trial details

NCT number: NCT03907540
Sponsor: Kadmon Corporation, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases Fibrosis

Start date: 2019-04-05
Primary completion: 2019-05-20
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.